Cannabidiol (CBD) in Pain Reduction for Knee Osteoarthritis
Status:
Not yet recruiting
Trial end date:
2023-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to see if cannabidiol (CBD) orally dissolving tablets (ODTs) can
lessen pain, improve function, and improve patient satisfaction in cases of knee
osteoarthritis. CBD comes from the cannabis plant and is non-psychoactive (i.e. does not
produce a 'high' or altered mental state) as compared to tetrahydrocannabinol (THC), another
compound found in cannabis. Researchers are studying different forms of CBD for potential use
in treating pain, inflammation, and illnesses.